Recent Company News

• 10:34 AM ET Dec 15, 2025
  

  StreetAccount M&A Summary: Week of 8-Dec

• 04:44 AM ET Dec 15, 2025
  

  StreetAccount Summary - Trading higher/lower: EU mid-morning

• 03:14 AM ET Dec 15, 2025
  

  Transcript Intelligence: Swedish Orphan Biovitrum Acquisition of Arthrosi Therapeutics, Inc AB Call (SEK329.60, 0.00)

• 02:08 PM ET Dec 13, 2025
  

  Sobi enters into a definitive agreement to acquire Arthrosi Therapeutics, Inc. (SEK 329.60, 0.00)

• 08:57 AM ET Dec 12, 2025
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 08:46 AM ET Dec 12, 2025
  

  EMA CHMP publishes summary of opinions for December 2025 meeting

• 08:02 AM ET Dec 12, 2025
  

  Sobi Receives Positive CHMP Opinion for Aspaveli (pegcetacoplan) for the Treatment of C3G and Primary IC-MPGN (SEK 329.00, -4.00)

• 06:35 AM ET Dec 10, 2025
  

  StreetAccount Summary - European unusual volume traders

• 06:20 AM ET Dec 09, 2025
  

  FDA to re-examine approved RSV treatments from AstraZeneca/Sanofi, Merck - Reuters

• 01:41 PM ET Dec 05, 2025
  

  Swedish Orphan Biovitrum to present latest clinical data & insights across hematology portfolio at ASH 2025 (SEK 342.60, 0.00)